These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19295312)

  • 1. Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management.
    Leitão CB; Cure P; Messinger S; Pileggi A; Lenz O; Froud T; Faradji RN; Selvaggi G; Kupin W; Ricordi C; Alejandro R
    Transplantation; 2009 Mar; 87(5):681-8. PubMed ID: 19295312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
    Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
    Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy.
    Gillard P; Rustandi M; Efendi A; Lee DH; Ling Z; Hilbrands R; Kuypers D; Mathieu C; Jacobs-Tulleneers-Thevissen D; Gorus F; Pipeleers D; Keymeulen B
    Transplantation; 2014 Aug; 98(4):451-7. PubMed ID: 24770614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.
    Warnock GL; Thompson DM; Meloche RM; Shapiro RJ; Ao Z; Keown P; Johnson JD; Verchere CB; Partovi N; Begg IS; Fung M; Kozak SE; Tong SO; Alghofaili KM; Harris C
    Transplantation; 2008 Dec; 86(12):1762-6. PubMed ID: 19104418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
    Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
    Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Routine Nephropathy Monitoring and Subsequent Change in Estimated Glomerular Filtration Rate in Patients With Diabetes Mellitus: A Japanese Non-Elderly Cohort Study.
    Ono S; Ono Y; Koide D; Yasunaga H
    J Epidemiol; 2020 Aug; 30(8):326-331. PubMed ID: 31204363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study).
    Yang CW; Park JT; Kim YS; Kim YL; Lee YS; Oh YS; Kang SW
    Nephrol Dial Transplant; 2011 Oct; 26(10):3249-55. PubMed ID: 21372264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimated glomerular filtration rate is associated with subclinical atherosclerosis, independently of albuminuria, in patients with type 2 diabetes.
    Lu B; Wan J; Yang Y; Li Y; Hu R
    Int Angiol; 2013 Oct; 32(5):532-9. PubMed ID: 23903314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014.
    Kume S; Araki SI; Ugi S; Morino K; Koya D; Nishio Y; Haneda M; Kashiwagi A; Maegawa H
    J Diabetes Investig; 2019 Jul; 10(4):1032-1040. PubMed ID: 30451386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in renal function after clinical islet transplantation: four-year observational study.
    Senior PA; Zeman M; Paty BW; Ryan EA; Shapiro AM
    Am J Transplant; 2007 Jan; 7(1):91-8. PubMed ID: 17227560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
    Zoppini G; Targher G; Chonchol M; Ortalda V; Negri C; Stoico V; Bonora E
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):401-8. PubMed ID: 22282481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients.
    Dahlquist G; Stattin EL; Rudberg S
    Nephrol Dial Transplant; 2001 Jul; 16(7):1382-6. PubMed ID: 11427629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transplant Proc; 2005 Mar; 37(2):1326-7. PubMed ID: 15848711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalbumin proteinuria in islet transplant recipients.
    Leitão CB; Froud T; Cure P; Tharavanij T; Pileggi A; Ricordi C; Alejandro R
    Cell Transplant; 2010; 19(1):119-25. PubMed ID: 19878623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
    Costacou T; Ellis D; Fried L; Orchard TJ
    Am J Kidney Dis; 2007 Nov; 50(5):721-32. PubMed ID: 17954285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
    Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
    Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [End-stage nephropathy in type 1-diabetes mellitus - kidney transplantation alone or combined with islet or pancreas transplantation?].
    Lehman R; Gerber PA
    Ther Umsch; 2011 Dec; 68(12):699-706. PubMed ID: 22139985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.
    Nijhoff MF; Engelse MA; Dubbeld J; Braat AE; Ringers J; Roelen DL; van Erkel AR; Spijker HS; Bouwsma H; van der Boog PJ; de Fijter JW; Rabelink TJ; de Koning EJ
    Am J Transplant; 2016 Jan; 16(1):246-53. PubMed ID: 26288226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.